Dr Dobrina Hull is an experienced Consultant Rheumatologist offering expert assessment and treatment across the full spectrum of rheumatological conditions.

She studied Medicine at the University of Oxford, graduating with a First Class Honours degree and a prize for excellence. She was appointed as Consultant Rheumatologist at Kingston Hospital in 2017.

She completed specialist training in Rheumatology within the London South Thames training programme and has worked at some of the UK’s leading specialist centres, which has given her extensive experience in the diagnosis and management of a broad range of rheumatological conditions. In 2009, she was awarded a clinical research fellowship at the prestigious Kennedy Institute of Rheumatology, where she undertook research investigating the effects of anti-TNF therapies on T-cell subsets in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and their relationship to treatment response. This led to the award of a PhD from the University of London in 2014 and developed her expertise in inflammatory arthritis and biologic therapies.

Alongside her expertise in rheumatoid arthritis and axial spondyloarthropathy, Dr Hull has a particular interest in the diagnosis and management of psoriatic arthritis, including early identification of symptoms and risk factors in people with psoriasis who may go on to develop inflammatory joint disease. She established and continues to run the joint rheumatology/dermatology clinic at Kingston Hospital, promoting close collaboration between specialties to support earlier diagnosis, coordinated care and improved outcomes for patients with psoriatic disease.

She also has a specialist interest in bone health, osteopenia and osteoporosis. Through her involvement in the South West London Bone Health Network and contribution to the development of a local fracture liaison service, she has built significant expertise in managing bone health and fracture risk. She is passionate about taking a proactive approach to bone health, particularly during midlife and the menopause transition, when hormonal changes and other risk factors may influence bone density and future fracture risk.

Dr Hull also has a dedicated clinical focus on musculoskeletal symptoms associated with menopause transition. She recognises the importance of understanding how hormonal changes may contribute to musculoskeletal symptoms, while identifying features that warrant investigation for an underlying rheumatological condition. She is also interested in how menopause affects pre‑existing rheumatic diseases and supporting women through this stage of life with an individualised and holistic approach.

Dr Hull remains actively involved in clinical research and is Principal Investigator for several studies. She has presented her work at national and international conferences, published papers in peer‑reviewed scientific journals and co‑authored chapters in the Oxford Handbook of Paediatric Rheumatology.

She has a keen interest in patient education and the education and development of allied health professionals, and delivers teaching to GPs, pharmacists, prescribing courses and patient forums.

She also plays an active role in the South-West London Rheumatology Clinical Network, contributing to regional projects aimed at improving rheumatology services and patient care.

Dr Hull is an experienced and compassionate rheumatologist who believes strongly in shared decision‑making and providing personalised, holistic, evidence‑based care. She is committed to ensuring timely diagnosis, clear communication and effective treatment plans that support long‑term health and wellbeing.

Dr Dobrina Hull has expertise in managing all aspects of rheumatological conditions, including:

• Inflammatory arthritis (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthropathies)
• Diagnosis and treatment of early inflammatory arthritis
• Crystal arthritis (including gout and pseudogout)
• Osteoarthritis
• Osteoporosis and osteopenia
• Bone health and fracture risk assessment
• Musculoskeletal symptoms during menopause transition
• Polymyalgia rheumatica
• Connective tissue diseases (e.g. Systemic Lupus Erythematosus, Sjogren’s syndrome, Scleroderma, Mixed connective tissue disease)
• Soft tissue rheumatic conditions and tendonitis, including shoulder pain, bursitis and tennis elbow
• Fibromyalgia
• She is highly proficient at performing joint and soft tissue injections.